Tonix Pharmaceuticals receives Paragraph IV notice for TONMYA generic

Tonix Pharmaceuticals has received a Paragraph IV ANDA notice from Dr. Reddy’s for a generic version of TONMYA sublingual tablets, 2.8 mg.